#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Postprandial hypoglycaemia Drug eruption Cutaneous T-cell lymphoma stage II Marginal zone lymphoma recurrent Hyperphagia Encephalopathy neonatal Arterial tortuosity syndrome Transitional cell cancer of the renal pelvis and ureter Peripheral primitive neuroectodermal tumour of soft tissue Cutaneous lupus erythematosus Rectal cancer Arterial disorder Neoplasm malignant Hereditary ataxia Thrombotic thrombocytopenic purpura More trials…

    Learn about Rare Diseases

    Cystic fibrosis – Life with Disease Cerebral arteriovenous malformation haemorrhagic – Diagnostics VEXAS syndrome – Life with Disease Haemolytic uraemic syndrome – Trials in Disease Urea cycle disorder – Trials in Disease Hepatoblastoma – Diagnostics Carcinoid syndrome – Basic Information Pituitary-dependent Cushing’s syndrome – Life with Disease Rhabdomyosarcoma recurrent – Treatment Ewing’s sarcoma recurrent – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ANXV Glenzocimab Inavolisib Dinutuximab Beta Ptg-Carcik-Cd19 Microcrystalline Cellulose Lerodalcibep APROTININ Pasireotide Diaspartate Syn321 Palivizumab Fadraciclib Meropenem Trihydrate Elvn-002-1 Interleukin-1 Dexlansoprazole ARI0008 Trientine Dihydrochloride Mk-0482 Venlafaxine Hydrochloride More therapies…

    Learn about Your Condition

    Urea cycle disorder Ocular melanoma End stage renal disease Cryoglobulinaemia Raynaud's phenomenon Colon cancer metastatic Peripheral artery restenosis Pneumonia Tertiary adrenal insufficiency Hypersensitivity Sciatica Infantile apnoea Inner ear disorder Vesicoureteric reflux Carcinoid syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. IRCCS Humanitas Research Hospital

IRCCS Humanitas Research Hospital

Via Alessandro Manzoni 56, Rozzano, 20089, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Benralizumab for Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) with Frequent Exacerbations

    Not recruiting

    3 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Benralizumab
    Austria Belgium Bulgaria Czechia Denmark Germany +7

  • Study on the Effectiveness and Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    3 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • 4-[3-(Cyanomethyl)-3-(3′,5′-Dimethyl-1H,1’H-[4,4′-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide
    Bulgaria Denmark France Germany Italy Poland +1

  • Study of Olezarsen (ISIS 678354) for Patients with High Triglycerides and Heart Disease or Severe High Triglycerides

    Not recruiting

    3 1
    Investigated Diseases:
    • Hypertriglyceridaemia
    • Arteriosclerosis
    Investigated Drugs:
    • Isis 678354 Sodium Salt
    Bulgaria Czechia Denmark Finland France Hungary +7

  • Study to Evaluate the Effectiveness of Spesolimab for Patients with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    4 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Spesolimab
    Austria Belgium Bulgaria Czechia Denmark Finland +11

  • Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1
    Investigated Drugs:
    • Obefazimod
    Belgium Bulgaria Croatia Czechia France Germany +8

  • Study on the Effects of Volrustomig and Drug Combination for Patients with Advanced Hepatobiliary Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Bile duct cancer
    • Gallbladder cancer
    • Cholangiocarcinoma
    Investigated Drugs:
    • Volrustomig
    • Bevacizumab
    • Cisplatin
    Italy Spain

  • Study on Fitusiran for Preventing Bleeding in Males Aged 12 and Older with Severe Hemophilia A or B, with or without Inhibitors

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Haemophilia
    Investigated Drugs:
    • Damoctocog Alfa Pegol
    • Factor Viii Inhibitor Bypassing Fraction
    • Fitusiran
    France Germany Greece Italy Poland Spain

  • Study of Subcutaneous Nivolumab with or without Recombinant Human Hyaluronidase PH20 for Patients with Lung, Kidney, Melanoma, Liver, Colorectal, or Bladder Cancer

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Nivolumab
    France Italy The Netherlands Poland Spain

  • Study on Bowel Urgency in Adults with Moderate to Severe Ulcerative Colitis Treated with Mirikizumab

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Mirikizumab
    Austria Belgium Czechia France Germany Hungary +3

  • Study on the Safety and Effectiveness of SerpinPC for Patients with Severe Hemophilia A or B

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Haemophilia A without inhibitors
    • Haemophilia B without inhibitors
    • Haemophilia A with anti factor VIII
    Belgium Bulgaria France Germany Italy Poland +1
Previous Page
1 … 62 63 64 65 66 … 69
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!